慢性静脈閉塞治療の世界市場レポート 2024

慢性静脈閉塞治療の市場規模は、今後数年間で大幅な成長が見込まれています。2028年には6.7%の年間複合成長率（CAGR）で86億7,000万米ドルに成長すると予想されます。予測期間で予想される成長は、静脈疾患に対する意識の高まり、低侵襲処置に対する需要の高まり、高齢化の動向、血管内治療の進歩、患者中心のケアへの重点化によるものと考えられます。予測期間中に予想される顕著な動向には、低侵襲処置の進歩、インターベンショナル放射線医学の技術革新、血管内治療への焦点、静脈疾患の有病率の増加、高齢化人口の増加が含まれます。

予想される肥満症例の増加は、将来の慢性静脈閉塞治療市場の成長を促進すると予想されます。肥満は体脂肪の過剰な蓄積を特徴とし、体格指数（BMI）が30以上となり、浮腫や皮膚の変化などの症状を伴うことがあります。慢性静脈閉塞の治療は、血流を改善し炎症を軽減することでこれらの症状の管理に重要な役割を果たし、効果的な肥満管理に貢献します。世界心臓連盟が2023年3月に報告したところによると、世界中で約23億人の成人と子供が肥満または過体重でした。現在の肥満傾向により、肥満者数は2025年までに27億人に達すると予測されています。したがって、肥満の有病率の増加は、慢性静脈閉塞治療市場の成長を推進する重要な要因となっています。

低侵襲処置の採用の増加により、慢性静脈閉塞治療市場の成長がさらに加速すると予想されます。低侵襲技術には、小さな切開または自然な身体開口部を通して行われる医療処置と外科処置が含まれ、感染、出血、瘢痕化などの合併症のリスクが軽減されます。慢性静脈閉塞の患者は基礎的な健康上の問題を抱えていることが多いため、合併症を最小限に抑えることが患者の全体的な健康にとって極めて重要です。2023年1月の国際美容形成外科学会によると、2021年に世界中で形成外科医が実施する手術は全体で19.3％増加し、外科手術が1,280万件以上、非外科的手術が1,750万件以上でした。したがって、低侵襲処置の採用の増加は、慢性静脈閉塞治療市場の成長の促進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の慢性静脈閉塞治療市場の促進要因と抑制要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の慢性静脈閉塞治療の市場規模実績と成長、2018年～2023年
• 世界の慢性静脈閉塞治療の市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の慢性静脈閉塞治療市場、製品別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 装置
• 薬剤
• 世界の慢性静脈閉塞治療市場、用途別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 静脈瘤
• 静脈うっ滞性潰瘍
• 浮腫
• 深部静脈血栓症
• その他の用途
• 世界の慢性静脈閉塞治療市場、エンドユーザー別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 病院
• クリニック
• 外来手術センター
• 外傷センター
• その他のエンドユーザー

第7章 地域と国の分析

• 世界の慢性静脈閉塞治療市場、地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 世界の慢性静脈閉塞治療市場、国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 慢性静脈閉塞治療市場の競合情勢
• 慢性静脈閉塞治療市場の企業プロファイル
  • Cardinal Health Inc.
  • Bayer AG
  • Sanofi SA
  • 3M Company
  • Bristol-Myers Squibb Company

第31章 その他の大手と革新的な企業

• Medtronic PLC
• Becton, Dickinson and Company（BD）
• Stryker Corporation
• Boston Scientific Corporation
• Terumo Corporation
• Ethicon Inc.
• Philips Medical Systems
• Teleflex Incorporated
• Cook Group Incorporated
• Merit Medical Systems Inc.
• Integer Holdings Corporation
• Penumbra Inc.
• Inari Medical
• Argon Medical Devices Inc.
• AngioDynamics Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Chronic venous occlusion refers to the prolonged blockage or obstruction of veins, commonly occurring in the legs or arms, which can hinder blood flow and result in various health issues such as swelling, pain, and skin changes. Treatment aims to alleviate symptoms, slow down the disease's progression, and prevent complications.

The primary categories of products within chronic venous occlusion treatment include devices and drugs. Devices encompass instruments, apparatuses, machines, or implants utilized for prevention, diagnosis, or treatment. In chronic venous occlusion treatment, devices play a crucial role in restoring proper blood flow and enhancing overall venous health, contributing to the success of treatment outcomes. These applications span various conditions, including varicose veins, venous stasis ulcers, edema, deep vein thrombosis, and others. They are utilized by hospitals, clinics, ambulatory surgery centers, trauma centers, and other healthcare facilities.

The chronic venous occlusions treatment market research report is one of a series of new reports from The Business Research Company that provides chronic venous treatment market statistics, including chronic venous occlusions treatment industry global market size, regional shares, competitors with a chronic venous occlusions treatment market share, detailed chronic venous occlusions treatment market segments, market trends and opportunities, and any further data you may need to thrive in the chronic venous occlusions treatment industry. This chronic venous occlusions treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic venous occlusions treatment market size has grown strongly in recent years. It will grow from $6.23 billion in 2023 to $6.7 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The increase observed in the historical period can be attributed to investments in treatment innovation, a rise in the prevalence of venous disorders, improvements in awareness and diagnosis, initiatives in clinical trials and research, and enhancements in patient outcomes and quality of life.

The chronic venous occlusions treatment market size is expected to see strong growth in the next few years. It will grow to $8.67 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The anticipated growth in the forecast period can be attributed to the increased awareness of venous disorders, a rising demand for minimally invasive procedures, the dynamics of an aging population, advancements in endovascular therapies, and a focus on patient-centric care. Prominent trends expected in the forecast period involve advancements in minimally invasive procedures, technological innovations in interventional radiology, a focus on endovascular therapies, the growing prevalence of venous disorders, and the rise in the aging population.

The anticipated rise in obesity cases is set to drive the growth of the chronic venous occlusion treatment market in the future. Obesity, characterized by an excessive accumulation of body fat leading to a body mass index (BMI) of 30 or higher, can be associated with symptoms such as edema and skin changes. Chronic venous occlusion treatment plays a crucial role in managing these symptoms by improving blood flow and reducing inflammation, contributing to effective obesity management. As reported in March 2023 by the World Heart Federation, around 2.3 billion adults and children globally were either obese or overweight. With the current obesity trend, it is projected that the number of individuals with obesity will reach 2.7 billion by 2025. Therefore, the increasing prevalence of obesity is a key factor propelling the growth of the chronic venous occlusion treatment market.

The growing adoption of minimally invasive procedures is expected to further fuel the growth of the chronic venous occlusion treatment market. Minimally invasive techniques involve medical and surgical procedures performed through small incisions or natural body openings, reducing the risk of complications such as infection, bleeding, and scarring. Given that patients with chronic venous occlusions often have underlying health issues, minimizing complications is crucial for their overall well-being. According to the International Society of Aesthetic Plastic Surgery in January 2023, there was a 19.3% overall increase in procedures performed by plastic surgeons globally in 2021, with over 12.8 million surgical and 17.5 million non-surgical procedures. Therefore, the growing adoption of minimally invasive procedures is a driving force behind the chronic venous occlusion treatment market's growth.

The high cost associated with chronic venous occlusion treatment is expected to pose a challenge to market growth during the forecast period. The substantial financial burden includes costs related to diagnosis and management of this medical condition, encompassing diagnostic procedures, medical devices, rehabilitation, and follow-up. As of March 2021, reluctance within the larger cardiology community to refer patients for percutaneous revascularization due to the perceived higher costs of complex procedures such as CTO PCI has been noted. This reluctance is attributed to a lack of appropriate knowledge about the potential clinical benefits. Therefore, the high cost of chronic venous occlusion treatment hampers the growth of the market.

Prominent companies in the chronic venous occlusion treatment market are strategically focusing on the development of minimally invasive devices, exemplified by innovations such as VenoValve, to gain a competitive edge. VenoValve, a minimally invasive device designed to prevent backward blood flow, was FDA-approved in August 2021. Hancock Jaffe Laboratories Inc., the developer of VenoValve, positions the device as a prosthetic valve implanted in deep leg veins to treat chronic venous occlusion. The device, acting as a one-way valve, is injected into the vein through a small incision in the thigh, and the procedure is typically performed under general anesthesia.

In December 2021, Becton, Dickinson, and Company (BD) acquired Venclose Inc., a medical technology company specializing in radiofrequency ablation (RFA) technologies for treating chronic venous occlusions. This strategic move is expected to expand BD's offerings in treating chronic venous insufficiency, providing physicians with innovative technologies for venous condition treatment.

Major companies operating in the chronic venous occlusions treatment market report are Cardinal Health Inc., Bayer AG, Sanofi S.A., 3M Company, Bristol-Myers Squibb Company, Medtronic PLC, Becton, Dickinson and Company (BD), Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Ethicon Inc., Philips Medical Systems, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Integer Holdings Corporation, Penumbra Inc., Inari Medical, Argon Medical Devices Inc., AngioDynamics Inc., Rontis Corporation, Endologix, Richard Wolf GmbH, SIGVARIS AG, enVVeno Medical Corporation, LimFlow SA

North America was the largest region in the chronic venous occlusions treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic venous occlusions treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chronic venous occlusions treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chronic venous occlusion treatment market consists of revenues earned by entities by providing services such as magnetic resonance imaging (MRI), fluoroscopy, computerized tomography (CT) scanning, anticoagulation therapy, and surgical intervention. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic venous occlusion treatment market also includes sales of anticoagulants, thrombolytic agents, pain relievers, and anti-inflammatory drugs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Venous Occlusions Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic venous occlusions treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic venous occlusions treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic venous occlusions treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Devices; Drugs
• 2) By Application: Varicose Veins; Venous Stasis Ulcers; Edema; Deep Vein Thrombosis; Other Applications
• 3) By End User: Hospitals; Clinics; Ambulatory Surgery Centers; Trauma centers; Other End-Users
• Companies Mentioned: Cardinal Health Inc.; Bayer AG; Sanofi S.A.; 3M Company; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Venous Occlusions Treatment Market Characteristics

3. Chronic Venous Occlusions Treatment Market Trends And Strategies

4. Chronic Venous Occlusions Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Chronic Venous Occlusions Treatment Market Size and Growth

• 5.1. Global Chronic Venous Occlusions Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Chronic Venous Occlusions Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Chronic Venous Occlusions Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Chronic Venous Occlusions Treatment Market Segmentation

• 6.1. Global Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Devices
• Drugs
• 6.2. Global Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Varicose Veins
• Venous Stasis Ulcers
• Edema
• Deep Vein Thrombosis
• Other Applications
• 6.3. Global Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgery Centers
• Trauma centers
• Other End-Users

7. Chronic Venous Occlusions Treatment Market Regional And Country Analysis

• 7.1. Global Chronic Venous Occlusions Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Chronic Venous Occlusions Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Chronic Venous Occlusions Treatment Market

• 8.1. Asia-Pacific Chronic Venous Occlusions Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Chronic Venous Occlusions Treatment Market

• 9.1. China Chronic Venous Occlusions Treatment Market Overview
• 9.2. China Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Chronic Venous Occlusions Treatment Market

• 10.1. India Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Chronic Venous Occlusions Treatment Market

• 11.1. Japan Chronic Venous Occlusions Treatment Market Overview
• 11.2. Japan Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Chronic Venous Occlusions Treatment Market

• 12.1. Australia Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Chronic Venous Occlusions Treatment Market

• 13.1. Indonesia Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Chronic Venous Occlusions Treatment Market

• 14.1. South Korea Chronic Venous Occlusions Treatment Market Overview
• 14.2. South Korea Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Chronic Venous Occlusions Treatment Market

• 15.1. Western Europe Chronic Venous Occlusions Treatment Market Overview
• 15.2. Western Europe Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Chronic Venous Occlusions Treatment Market

• 16.1. UK Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Chronic Venous Occlusions Treatment Market

• 17.1. Germany Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Chronic Venous Occlusions Treatment Market

• 18.5. France Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.6. France Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.7. France Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Chronic Venous Occlusions Treatment Market

• 19.9. Italy Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.10. Italy Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.11. Italy Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Chronic Venous Occlusions Treatment Market

• 20.13. Spain Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.14. Spain Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.15. Spain Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Chronic Venous Occlusions Treatment Market

• 21.1. Eastern Europe Chronic Venous Occlusions Treatment Market Overview
• 21.2. Eastern Europe Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Chronic Venous Occlusions Treatment Market

• 22.1. Russia Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Chronic Venous Occlusions Treatment Market

• 23.1. North America Chronic Venous Occlusions Treatment Market Overview
• 23.2. North America Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Chronic Venous Occlusions Treatment Market

• 24.1. USA Chronic Venous Occlusions Treatment Market Overview
• 24.2. USA Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Chronic Venous Occlusions Treatment Market

• 25.1. Canada Chronic Venous Occlusions Treatment Market Overview
• 25.2. Canada Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Chronic Venous Occlusions Treatment Market

• 26.1. South America Chronic Venous Occlusions Treatment Market Overview
• 26.2. South America Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Chronic Venous Occlusions Treatment Market

• 27.1. Brazil Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Chronic Venous Occlusions Treatment Market

• 28.1. Middle East Chronic Venous Occlusions Treatment Market Overview
• 28.2. Middle East Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Chronic Venous Occlusions Treatment Market

• 29.1. Africa Chronic Venous Occlusions Treatment Market Overview
• 29.2. Africa Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Chronic Venous Occlusions Treatment Market Competitive Landscape And Company Profiles

• 30.1. Chronic Venous Occlusions Treatment Market Competitive Landscape
• 30.2. Chronic Venous Occlusions Treatment Market Company Profiles
  • 30.2.1. Cardinal Health Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bayer AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Sanofi S.A.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. 3M Company
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bristol-Myers Squibb Company
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Chronic Venous Occlusions Treatment Market Other Major And Innovative Companies

• 31.1. Medtronic PLC
• 31.2. Becton, Dickinson and Company (BD)
• 31.3. Stryker Corporation
• 31.4. Boston Scientific Corporation
• 31.5. Terumo Corporation
• 31.6. Ethicon Inc.
• 31.7. Philips Medical Systems
• 31.8. Teleflex Incorporated
• 31.9. Cook Group Incorporated
• 31.10. Merit Medical Systems Inc.
• 31.11. Integer Holdings Corporation
• 31.12. Penumbra Inc.
• 31.13. Inari Medical
• 31.14. Argon Medical Devices Inc.
• 31.15. AngioDynamics Inc.

32. Global Chronic Venous Occlusions Treatment Market Competitive Benchmarking

33. Global Chronic Venous Occlusions Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Chronic Venous Occlusions Treatment Market

35. Chronic Venous Occlusions Treatment Market Future Outlook and Potential Analysis

• 35.1 Chronic Venous Occlusions Treatment Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Chronic Venous Occlusions Treatment Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Chronic Venous Occlusions Treatment Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer